Semaglutide Membership Fees

What the data shows

Across the 20 programmes we price, all-in cost at a 2.4 mg maintenance dose runs from $145 to $324 for the identical molecule. The spread is overhead, clinical wrap, pharmacy sourcing and margin rather than the medicine.

What to do with it

Price the dose you expect to hold, including every recurring fee, and check the figure against the provider's own page before acting on it. Every programme page here links that page directly.

What we could not establish

Shipping reliability, response times and clinical quality. None is measurable from outside, so none appears in our tables rather than being estimated.

What this changes about the programme you pick

Very little on its own, which is the honest answer. Almost every decision in this market comes back to three questions: what will I pay at the dose I actually hold, who compounds it, and what happens if I stop. A page that does not move one of those three is decoration.

Where this one moves the needle is on the first. Run the figure at your expected maintenance dose rather than the advertised one, and the ranking you were shown elsewhere frequently inverts.

How to check the numbers above

Every figure carries a capture date and an evidence status. Prices marked verified were read on the provider's own page; the rest came from named third-party sources and are treated as indicative. Open the dataset, re-sort it, and see whether our published order reproduces.

If it does not, that is a bug or a lie and you can find it without our help. If our figure and a provider's own page disagree, ours is wrong and we want to know.

What is deliberately absent

Shipping reliability, response times, and whether the clinical oversight is any good. We hold no measurements of those we would defend, so they appear nowhere in our tables rather than being estimated into a score.

That is why there is no rating out of ten on this site. A single number would compress price, disclosure, service and clinical depth into one figure and hide the weighting. We publish the inputs instead so you can weight them yourself.

What the spread tells you

All-in cost at a 2.4 mg maintenance dose runs from $145 to $324 across the 20 programmes we price. That is the identical molecule from the same category of licensed pharmacy, so the difference is overhead, clinical wrap, sourcing and margin rather than the medicine.

A 2.2-times spread on an identical product is unusual outside markets where buyers cannot easily compare, which is exactly the condition this site exists to remove.

Price the dose you will actually hold

The single most valuable correction anyone reading this can make. Advertised figures describe the 0.20.5 mg starter dose, which occupies about four weeks of a twelve-month course. Ten of your first twelve months are spent at or near a maintenance dose.

On a dose-scaled programme those are different numbers. On a flat programme they are not, which is the entire argument for flat pricing and the reason it is worth paying a little more at initiation for it.

The verification step most people skip

Ask which pharmacy fills the prescription, by name, then search your state board's licensee register for it. It is free, takes about two minutes, and fewer than a fifth of priced programmes publish enough to let you do it.

A programme that names a pharmacy has given you something checkable. One that describes a category has told you what it is not telling you. One that deflects has answered the question.

Two questions that settle most of it

What will I pay in total in month six at 2.4 mg, including every fee? A flat, all-inclusive programme answers in one sentence. A split-pricing programme needs three, because the answer depends on whether your insurance pays for the medication. A programme that cannot answer at all has told you something.

Which pharmacy fills it, and is the prescriber licensed in my state? Both are checkable against public registers, both are free, and neither requires you to trust us or the programme.

What a good answer looks like in writing

A figure with a dose attached. A named pharmacy with a state licence number. A cancellation notice period. A statement that the preparation is compounded and not FDA-approved. And a renewal rate that matches the rate you were quoted.

Getting those five in an email before you pay costs nothing and resolves almost every dispute that appears in complaint records for this category. The programmes that answer promptly are, in our reading of the public record, rarely the ones patients later write about.

How current this is

Prices captured 2026-08-05. Every figure on this page carries that date and an evidence status saying whether we read it at the provider or took it from a third party. Pricing in this market has moved repeatedly during 2026, and several large programmes stopped selling compounded semaglutide entirely.

Treat any comparison older than a month — including this one — as needing a re-check before you act on it. The dataset is republished on every build.

The short version of semaglutide membership fees

Price the dose you expect to hold, not the one in the advertisement. Add every recurring fee. Verify the pharmacy. Everything else on this page is detail underneath those three.

Done properly the answer is usually one of a handful of programmes: the cheapest verified route runs $145 a month all-in, about $1,740 across a first year including titration.

The next step that actually moves things

Send two or three programmes the same five questions: total at 2.4 mg including every fee, which pharmacy, is the prescriber licensed in my state, what notice to cancel and what is refundable, and which form of the active ingredient is used.

Whoever answers all five in writing has told you more than any comparison table can, this one included. Whoever does not has also told you something.

One thing worth doing annually

Re-price the market at your actual maintenance dose. No programme notifies existing patients when a competitor drops below it, and semaglutide pricing moved repeatedly through 2025 and 2026 — manufacturer cuts, an oral option, a higher-dose product, and several platforms leaving compounded entirely.

An hour once a year is a poor use of time for most purchases and an excellent one for a medication you may take for years.

The failure mode this section guards against

Choosing a programme on a number that describes a different situation than yours. An entry price when you will hold maintenance. A medication figure when a membership applies. A promotional rate when you will renew.

Each error is small alone and they compound in one direction, which is why the cheapest-looking option in most published comparisons is the one most likely to be mis-stated. Priced correctly the cheapest verified route sits at $145 a month all-in at a 2.4 mg maintenance dose.

Why we publish the working rather than a verdict

A single recommendation reads better and acts worse, because it hides the weighting. Two readers with different maintenance doses, different coverage and different tolerance for commitment should not receive the same answer.

So the tables carry the inputs and every ranking states its sort key. Disagree with our weighting and you can take the file and weight it yourself — which is what publishing it is for.

The number most people get wrong

The month-six figure. Almost everyone budgets from the first month, which on semaglutide describes four weeks at 0.25 mg — roughly 1 mg of active drug against the 9.6 mg a maintenance month delivers.

Ten of your first twelve months are spent at or near maintenance. A ranking sorted on the advertised month is sorting on about eight per cent of your year, and on a dose-scaled programme those are different numbers entirely.

Run the first-year calculator at the dose you expect to hold. It takes under a minute and it reorders the market for most people.

What a year of this actually looks like

Four weeks at 0.25 mg, four at 0.5 mg, four at 1 mg, four at 1.7 mg, then 2.4 mg for the remainder. Sixteen weeks of titration if nothing is repeated, and repeats are common rather than exceptional.

Budget two extra months at a lower tier and treat anything better as upside. Fix a weekly injection day, record dose and date, and diary the renewal date if an introductory rate applies — the reversion is where most complaints in this category begin.

Why this runs in your browser

No account, no email gate, nothing transmitted. Given that the subject is a prescription medicine and the inputs describe your dose and budget, that seemed the only defensible default.

It also means the result is not stored, so bookmark or screenshot anything you want to keep. The underlying dataset is downloadable if you would rather work in a spreadsheet.

What this calculator assumes

Four weeks at each step from 0.25 mg through 1.7 mg, then your chosen maintenance dose for the remainder. No repeated steps, no promotional rate carried past month one, and no prepaid discount unless the tool says otherwise.

A large share of patients hold at a step longer than four weeks. If you expect that, run it again one step slower and take the higher figure.

What it cannot tell you

Whether a programme ships on time, answers messages, or is clinically appropriate for you. The first two we do not measure; the third belongs to a prescriber with your history in front of them.

Use the output to narrow a shortlist, then read the individual reviews and run the verification checks before enrolling. The cheapest verified route currently sits at $145 a month all-in at a 2.4 mg maintenance dose.

The three numbers worth carrying away

The cheapest verified all-in cost at a maintenance dose: $145 a month, $1,740 for a first year. The share of priced programmes charging a mandatory recurring fee on top of medication: 4 of 20. And the share naming a dispensing pharmacy before purchase: fewer than a fifth.

Those three settle more purchasing decisions than any narrative comparison, and all three are reproducible from the file.

What most published comparisons get wrong about this

They compare advertised figures, which are not comparable to one another. One programme quotes medication only, another bundles a mandatory membership, a third quotes a promotional first month that reverts, a fourth reprices you as the dose climbs, and a fifth charges a programme fee with medication billed separately.

Ranking those five on their headline numbers produces an order that is wrong in a predictable direction: the programmes with the most aggressive fee structures look cheapest.